T Ebert

Summary

Country: Germany

Publications

  1. ncbi [Dietary prevention of carcinomas of the breast and prostate: fundamental and practical aspects of the Nutritional Cancer Prevention (NCP) program]
    T Ebert
    Urologische Abteilung, Euromed Clinic,
    Dtsch Med Wochenschr 127:1392-6. 2002
  2. ncbi [When is aftercare useful in renal cell cancer?]
    T Ebert
    Urologische Belegabteilung, EuromedClinic, Fürth
    Urologe A 44:1018, 1020-3. 2005
  3. ncbi The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel
    T Ebert
    Department of Urology, Euromed Clinic, Europa Allee 1, D 90763 Fürth, Germany
    Eur Urol 47:137-46. 2005
  4. ncbi [Lymph node dissection in patients with renal cell carcinoma]
    T Ebert
    Urologische Belegabteilung, EuromedClinic, Fürth
    Urologe A 44:635-7. 2005
  5. ncbi Nutrition and prostate cancer
    B J Schmitz-Dräger
    Urology, EuromedClinic, Fürth, Germany
    Urol Int 67:1-11. 2001
  6. ncbi Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis
    A G Anastasiadis
    Department of Urology, Heinrich Heine University, Dusseldorf, Germany
    Anticancer Res 19:2105-10. 1999
  7. ncbi [Local recurrence of prostate cancer: hormone therapy]
    J E Altwein
    Urologische Abteilung, Krankenhaus Barmherzige Brüder, Akademisches Lehrkrankenhaus, Technische Universitat, Romanstrasse 93, 80639, Munchen, Germany
    Urologe A 45:1276, 1278-82. 2006
  8. ncbi Immunocytology in the assessment of patients with asymptomatic hematuria
    B J Schmitz-Dräger
    Urologie, EuromedClinic, Europa Allee 1, 90763 Fürth, Germany
    World J Urol 26:31-7. 2008
  9. ncbi [Analyses of the role of immunocytology in the differential diagnosis of patients with asymptomatic microhematuria]
    B J Schmitz-Dräger
    Urologie, EuromedClinic, Europa Allee 1, 90763, Fürth
    Urologe A 47:190-4. 2008
  10. ncbi Clinical experiences with testosterone therapy: prostate safety
    T Ebert
    EuromedClinic, , Germany
    Aging Male 7:304-11. 2004

Collaborators

Detail Information

Publications17

  1. ncbi [Dietary prevention of carcinomas of the breast and prostate: fundamental and practical aspects of the Nutritional Cancer Prevention (NCP) program]
    T Ebert
    Urologische Abteilung, Euromed Clinic,
    Dtsch Med Wochenschr 127:1392-6. 2002
  2. ncbi [When is aftercare useful in renal cell cancer?]
    T Ebert
    Urologische Belegabteilung, EuromedClinic, Fürth
    Urologe A 44:1018, 1020-3. 2005
    ..g., frequency, localization, or therapeutic options). Available data lend support to "lean" follow-up strategies in patients with renal cell carcinoma...
  3. ncbi The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel
    T Ebert
    Department of Urology, Euromed Clinic, Europa Allee 1, D 90763 Fürth, Germany
    Eur Urol 47:137-46. 2005
    ....
  4. ncbi [Lymph node dissection in patients with renal cell carcinoma]
    T Ebert
    Urologische Belegabteilung, EuromedClinic, Fürth
    Urologe A 44:635-7. 2005
    ..Retrospective analyses were not able to demonstrate a diagnostic or therapeutic benefit of an extended lymph node dissection. Suspicious lymph nodes (imaging, palpation) should be excised during nephrectomy...
  5. ncbi Nutrition and prostate cancer
    B J Schmitz-Dräger
    Urology, EuromedClinic, Fürth, Germany
    Urol Int 67:1-11. 2001
    ..However, regarding the potential relevance of chemoprevention on public health, further efforts to identify nutritional factors affecting prostate cancer growth are warranted...
  6. ncbi Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis
    A G Anastasiadis
    Department of Urology, Heinrich Heine University, Dusseldorf, Germany
    Anticancer Res 19:2105-10. 1999
    ..Human renal cell carcinogenesis is associated with loss of expression of tissue-specific genes and loss of function of tissue-specific transcription factors such as HNF(hepatic nuclear factor)1 alpha...
  7. ncbi [Local recurrence of prostate cancer: hormone therapy]
    J E Altwein
    Urologische Abteilung, Krankenhaus Barmherzige Brüder, Akademisches Lehrkrankenhaus, Technische Universitat, Romanstrasse 93, 80639, Munchen, Germany
    Urologe A 45:1276, 1278-82. 2006
    ..It is difficult to differentiate at a low rise in PSA level, e.g., <or=1 ng/ml, between local or systemic recurrence...
  8. ncbi Immunocytology in the assessment of patients with asymptomatic hematuria
    B J Schmitz-Dräger
    Urologie, EuromedClinic, Europa Allee 1, 90763 Fürth, Germany
    World J Urol 26:31-7. 2008
    ..In patients with microhematuria immunocytology could be used to select for patients at risk for urothelial cancer and thus spare negative patients from further examinations...
  9. ncbi [Analyses of the role of immunocytology in the differential diagnosis of patients with asymptomatic microhematuria]
    B J Schmitz-Dräger
    Urologie, EuromedClinic, Europa Allee 1, 90763, Fürth
    Urologe A 47:190-4. 2008
    ..In this prospective study the role of immunocytology in the assessment microhematuria was studied...
  10. ncbi Clinical experiences with testosterone therapy: prostate safety
    T Ebert
    EuromedClinic, , Germany
    Aging Male 7:304-11. 2004
    ..Steadily rising PSA levels require immediate cessation of testosterone administration and the initiation of further diagnostic procedures (prostate biopsy), to rule out prostate cancer...
  11. ncbi [Role of immunocytology in the evaluation of patients with painless gross hematuria]
    B J Schmitz-Dräger
    Urologie, EuromedClinic, Europa Allee 1, 90763, Fürth, Germany
    Urologe A 49:741-6. 2010
    ..In this prospective study the role of immunocytology in the evaluation of patients with gross hematuria was investigated...
  12. ncbi Simultaneous diagnosis of a metanephric adenoma and a clear cell carcinoma of the contralateral kidney
    A G Anastasiadis
    Department of Urology, Heinrich Heine University Medical Center, Dusseldorf, Germany
    Eur Urol 39:236-9. 2001
    ..A clear cell carcinoma of the contralateral kidney was also discovered and treated...
  13. ncbi p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?
    B J Schmitz-Dräger
    Urology, Euromed Clinic, Fürth, Germany
    Eur Urol 38:691-9;discussion 700. 2000
    ..Furthermore, putative reasons for the conflicting results should be defined as a basis for future research...
  14. ncbi [Cooperative patient care at the Euromed Clinic]
    T Ebert
    Urologische Partnerschaft, EuromedClinic,
    Urologe A 43:22-7. 2004
  15. ncbi [Nutrition, lifestyle, physical activity, and supportive care during chemotherapeutic treatment]
    G Lümmen
    Klinik für Urologie und Kinderurologie, St Agnes Hospital, Barloer Weg 125, 46397, Bocholt
    Urologe A 45:555-8, 560-5. 2006
    ..There are several colony-stimulating factors (e.g. GCSF, erythropoietin) for hematopoietic recovery post-chemotherapy. Altogether supportive care of chemotherapy reduces toxicity and increases efficacy...
  16. ncbi FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival
    U Ramp
    Institute of Pathology, Heinrich Heine University, 40225 Duesseldorf, Germany
    J Pathol 196:430-6. 2002
    ..This versatility of FHIT expression during tumour progression suggests a role for reversible mechanisms of FHIT inactivation during the initiation and progression of clear cell RCCs...
  17. ncbi Level ground and uphill cycling ability in elite female mountain bikers and road cyclists
    F M Impellizzeri
    Human Performance Laboratory, Mapei Sport Research Center, Castellanza, Varese, Italy
    Eur J Appl Physiol 102:335-41. 2008
    ..This suggests that, as for male professional cyclists, top level time trialists have an overall performance advantage over all types of terrain...